Scopus:
Postmenopausal estrogen receptor positive breast cancer and obesity associated gene variants

dc.contributor.authorÖzgöz A.
dc.contributor.authorİçduygu F.M.
dc.contributor.authorYükseltürk A.
dc.contributor.authorŞamli H.
dc.contributor.authorÖztürk K.H.
dc.contributor.authorBaşkan Z.
dc.contributor.authorTütüncü İ.
dc.date.accessioned2023-04-12T00:57:08Z
dc.date.available2023-04-12T00:57:08Z
dc.date.issued2021-01-01
dc.description.abstractObesity is one of the most important health risks in postmenopausal women. Molecular pathways that are connected with obesity are believed to interact with the pathogenesis of breast cancer (BC). The aim of this research was to study the polymorphisms of two obesity-associated genes ADIPOQ and FTO that are also related to the pathogenesis of BC. Obesity-associated gene polymorphisms ADIPOQ rs1501299 and rs2241766, and FTO rs1477196, rs7206790, rs8047395, and rs9939609 were studied in 101 Turkish postmenopausal estrogen receptor-positive BC patients and 100 healthy control individuals. ADIPOQ rs1501299 was detected to be associated with protection against BC. The ADIPOQ rs1501299 TT genotype, the rs2241766 GT genotype and the G allele were found to be significantly higher in the control group. In addition, ADIPOQ rs1501299 polymorphism was protective in the recessive model and rs2241766 polymorphism was protective in the dominant model. While none of the FTO gene polymorphisms were found to be associated with BC, the frequencies of rs9939609 A allele and rs7206790 G allele were correlated with body mass index (BMI) in BC patients. ADIPOQ rs1501299 TT genotype, rs2241766 GT genotype, and G allele might be protective against BC in the Turkish population but this conclusion needs to be further verified.
dc.identifier.doi10.17179/excli2020-2860
dc.identifier.scopus2-s2.0-85111114064
dc.identifier.urihttps://hdl.handle.net/20.500.12597/4562
dc.relation.ispartofEXCLI Journal
dc.rightsfalse
dc.subjectADIPOQ | Breast cancer | FTO | Polymorphism | Postmenopausal
dc.titlePostmenopausal estrogen receptor positive breast cancer and obesity associated gene variants
dc.typeArticle
dspace.entity.typeScopus
oaire.citation.volume20
person.affiliation.nameKastamonu University
person.affiliation.nameGiresun Üniversitesi
person.affiliation.nameKastamonu University
person.affiliation.nameBursa Uludağ Üniversitesi
person.affiliation.nameSüleyman Demirel University, Faculty of Medicine
person.affiliation.nameAcibadem Bursa Hospital
person.affiliation.nameKastamonu University
person.identifier.scopus-author-id34868587800
person.identifier.scopus-author-id35219994700
person.identifier.scopus-author-id57195991651
person.identifier.scopus-author-id6507670789
person.identifier.scopus-author-id55675224267
person.identifier.scopus-author-id8267296200
person.identifier.scopus-author-id57226301775
relation.isPublicationOfScopus3e3987a0-b121-44da-84f9-cdae9583693a
relation.isPublicationOfScopus.latestForDiscovery3e3987a0-b121-44da-84f9-cdae9583693a

Files